Literature DB >> 20865468

Chronic headaches and medication overuse.

Pierangelo Geppetti1, Francesco De Cesaris, Paola Nicoletti, Silvia Benemei.   

Abstract

Chronic headaches represent a significant burden for the affected individuals and for the society, and a major challenge for successful care. Among the various types of chronic headaches, those that are associated with medication overuse (medication-overuse headache, MOH) are of particular importance because of the large proportion of patients who complain of this condition and their poor outcome. Most patients with MOH had migraine as primary headache. Practically, almost all drugs used for the symptomatic relief of migraine, including triptans and analgesics can cause MOH. Although the pathophysiology of MOH is unknown, recent studies hypothesize that plastic changes in specific pain areas of the central nervous system are main contributors to establishing MOH. Not infrequently, drug overuse is associated with habituation and failure of previously effective medications. Finally, treatment of MOH is poorly evidence based and mostly relies on clinical experience and belief.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865468     DOI: 10.1007/s11739-010-0461-y

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  4 in total

1.  Pain in patients attending outpatient rehabilitation: results of a pilot study.

Authors:  Francesca Cecchi; Anita Paperini; Raffaello Molino Lova; Guido Pasquini; Roberta Boni; Chiara Castagnoli; Federica Vannetti; Luca Padua; Claudio Macchi
Journal:  Intern Emerg Med       Date:  2015-02-10       Impact factor: 3.397

2.  Self-reported comorbid pains in severe headaches or migraines in a US national sample.

Authors:  Octavia Plesh; Sally H Adams; Stuart A Gansky
Journal:  Headache       Date:  2012-05-03       Impact factor: 5.887

Review 3.  Migraine and Neuroticism: A Scoping Review.

Authors:  Carmen M Galvez-Sánchez; Casandra I Montoro Aguilar
Journal:  Behav Sci (Basel)       Date:  2022-01-28

Review 4.  Anti-CGRP monoclonal antibodies in migraine: current perspectives.

Authors:  Maria Adele Giamberardino; Giannapia Affaitati; Martina Curto; Andrea Negro; Raffaele Costantini; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2016-06-23       Impact factor: 3.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.